Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Macaya Douoguih"'
Autor:
Jerald, Sadoff, Glenda, Gray, An, Vandebosch, Vicky, Cárdenas, Georgi, Shukarev, Beatriz, Grinsztejn, Paul A, Goepfert, Carla, Truyers, Ilse, Van Dromme, Bart, Spiessens, Johan, Vingerhoets, Jerome, Custers, Gert, Scheper, Merlin L, Robb, John, Treanor, Martin F, Ryser, Dan H, Barouch, Edith, Swann, Mary A, Marovich, Kathleen M, Neuzil, Lawrence, Corey, Jeffrey, Stoddard, Karin, Hardt, Javier, Ruiz-Guiñazú, Mathieu, Le Gars, Hanneke, Schuitemaker, Johan, Van Hoof, Frank, Struyf, Macaya, Douoguih, Marcus, Zervos
Publikováno v:
The New England journal of medicine. 386(9)
The Ad26.COV2.S vaccine was highly effective against severe-critical coronavirus disease 2019 (Covid-19), hospitalization, and death in the primary phase 3 efficacy analysis.We conducted the final analysis in the double-blind phase of our multination
Autor:
Jinyan Liu, Dan H. Barouch, Mathieu Le Gars, Dirk Heerwegh, Makda S. Gebre, Katherine McMahan, Johan Van Hoof, Aiquan Chang, Jingyou Yu, Anne Marit de Groot, Macaya Douoguih, Kathryn E. Stephenson, Abishek Chandrashekar, Jerald C. Sadoff, Shivani A. Patel, Frank Struyf, Hanneke Schuitemaker
Publikováno v:
medRxiv
article-version (status) pre
article-version (number) 1
article-version (status) pre
article-version (number) 1
Interim immunogenicity and efficacy data for the Ad26.COV2.S vaccine for COVID-19 have recently been reported1–3. We describe here the 8-month durability of humoral and cellular immune responses in 20 individuals who received one or two doses of 5
Publikováno v:
The New England journal of medicine. 385(3)
Publikováno v:
The New England Journal of Medicine
Thrombotic Thrombocytopenia after Ad26.COV2.S Vaccination — Manufacturer’s Response The manufacturer of the Ad26.COV2.S vaccine against Covid-19 comments on recent reports of thrombosis, including ...
Autor:
Hanneke Schuitemaker, Jerald C. Sadoff, Gert Scheper, Jeroen Stoop, Emmanuel Cormier, Pierre Van Damme, Isabel Leroux-Roels, Johan Van Hoof, Anne Marit de Groot, Wim Van Damme, Frank Struyf, Sarah Tete, Carla Truyers, Mathieu Le Gars, Jenny Hendriks, William T. Smith, Murray Kimmel, Dirk Heerwegh, Kristen W. Cohen, Georgi Shukarev, Jan de Hoon, M Juliana McElrath, Macaya Douoguih, Dan H. Barouch, Stephen C De Rosa, Pieter-Jan Berghmans, Kathryn E. Stephenson
Publikováno v:
The New England Journal of Medicine
New England Journal of Medicine
NEW ENGLAND JOURNAL OF MEDICINE
The New England journal of medicine
New England Journal of Medicine
NEW ENGLAND JOURNAL OF MEDICINE
The New England journal of medicine
BACKGROUND: Efficacious vaccines are urgently needed to contain the ongoing coronavirus disease 2019 (Covid-19) pandemic of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). A candidate vaccine, Ad26.COV2.S, is a recombinan